Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis
JA Stratmann, R Timalsina, A Atmaca… - Therapeutic …, 2022 - journals.sagepub.com
Objectives: Small-cell lung cancer (SCLC) is a lung malignancy with high relapse rates and
poor survival outcomes. Treatment-resistant disease relapse occurs frequently and effective …
poor survival outcomes. Treatment-resistant disease relapse occurs frequently and effective …
[HTML][HTML] Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world …
JA Stratmann, R Timalsina, A Atmaca… - … Advances in Medical …, 2022 - ncbi.nlm.nih.gov
Objectives: Small-cell lung cancer (SCLC) is a lung malignancy with high relapse rates and
poor survival outcomes. Treatment-resistant disease relapse occurs frequently and effective …
poor survival outcomes. Treatment-resistant disease relapse occurs frequently and effective …
Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis.
JA Stratmann, R Timalsina, A Atmaca… - Therapeutic …, 2022 - search.ebscohost.com
Objectives: Small-cell lung cancer (SCLC) is a lung malignancy with high relapse rates and
poor survival outcomes. Treatment-resistant disease relapse occurs frequently and effective …
poor survival outcomes. Treatment-resistant disease relapse occurs frequently and effective …
Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis.
JA Stratmann, R Timalsina, A Atmaca… - … Advances in Medical …, 2022 - europepmc.org
Objectives Small-cell lung cancer (SCLC) is a lung malignancy with high relapse rates and
poor survival outcomes. Treatment-resistant disease relapse occurs frequently and effective …
poor survival outcomes. Treatment-resistant disease relapse occurs frequently and effective …
Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis
JA Stratmann, R Timalsina… - Therapeutic …, 2022 - pubmed.ncbi.nlm.nih.gov
Objectives Small-cell lung cancer (SCLC) is a lung malignancy with high relapse rates and
poor survival outcomes. Treatment-resistant disease relapse occurs frequently and effective …
poor survival outcomes. Treatment-resistant disease relapse occurs frequently and effective …